Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $14.8900 (-2.68%) ($14.8900 - $14.8900) on Wed. Sep. 8, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.04% (three month average) | RSI | 73 | Latest Price | $14.8900(-2.68%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.1% a day on average for past five trading days. | Weekly Trend | ATRA advances 9.7% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) ARKG(45%) ARKK(45%) IBB(45%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -1.52% in a week (0% probabilities). VIXM(-37%) VXX(-27%) IGOV(-16%) UNG(-13%) USO(-10%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.52% (StdDev 3.04%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $15.52(-4.06%) | 10 Day Moving Average | $15.01(-0.8%) | 20 Day Moving Average | $13.9(7.12%) | To recent high | -10.1% | To recent low | 24% | Market Cap | $1.106b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |